Synovus Financial Corp lowered its stake in shares of Danaher Co. (NYSE:DHR) by 0.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 122,593 shares of the conglomerate’s stock after selling 318 shares during the quarter. Synovus Financial Corp’s holdings in Danaher were worth $12,636,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc grew its holdings in Danaher by 1.4% in the 3rd quarter. Vanguard Group Inc now owns 44,738,984 shares of the conglomerate’s stock worth $4,861,338,000 after acquiring an additional 605,018 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of Danaher by 0.9% in the third quarter. BlackRock Inc. now owns 43,427,529 shares of the conglomerate’s stock worth $4,718,836,000 after buying an additional 396,818 shares in the last quarter. FMR LLC lifted its holdings in shares of Danaher by 3.5% in the third quarter. FMR LLC now owns 21,739,751 shares of the conglomerate’s stock worth $2,362,241,000 after buying an additional 728,725 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its holdings in shares of Danaher by 10,085.3% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,863,048 shares of the conglomerate’s stock worth $67,000 after buying an additional 6,795,666 shares in the last quarter. Finally, Putnam Investments LLC lifted its holdings in shares of Danaher by 1.4% in the third quarter. Putnam Investments LLC now owns 6,476,522 shares of the conglomerate’s stock worth $703,739,000 after buying an additional 91,519 shares in the last quarter. Hedge funds and other institutional investors own 76.90% of the company’s stock.

Danaher stock traded up $0.31 during mid-day trading on Wednesday, reaching $111.63. 17,552 shares of the company’s stock traded hands, compared to its average volume of 2,226,141. The company has a market cap of $77.74 billion, a price-to-earnings ratio of 24.72, a PEG ratio of 2.05 and a beta of 0.99. The company has a quick ratio of 1.07, a current ratio of 1.47 and a debt-to-equity ratio of 0.34. Danaher Co. has a 12-month low of $94.59 and a 12-month high of $111.82.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The business had revenue of $5.40 billion for the quarter, compared to analysts’ expectations of $5.33 billion. During the same quarter in the previous year, the business posted $1.19 earnings per share. The business’s revenue was up 6.2% compared to the same quarter last year. On average, equities research analysts anticipate that Danaher Co. will post 4.78 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 25th. Shareholders of record on Friday, December 28th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date of this dividend was Thursday, December 27th. Danaher’s dividend payout ratio (DPR) is 14.16%.

DHR has been the topic of several research analyst reports. Royal Bank of Canada reissued a “hold” rating and issued a $102.00 target price on shares of Danaher in a report on Wednesday, December 19th. Needham & Company LLC initiated coverage on shares of Danaher in a report on Wednesday, January 2nd. They issued a “buy” rating and a $114.00 target price on the stock. Finally, Cowen reissued a “buy” rating and issued a $110.00 target price on shares of Danaher in a report on Monday, January 7th. Two equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $113.08.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Daily Political and is owned by of Daily Political. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.dailypolitical.com/2019/02/20/synovus-financial-corp-lowers-stake-in-danaher-co-dhr.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Recommended Story: Market Capitalization – What it Means for Investors

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.